Business description: Advanced Medical Solutions Group plc

Advanced Medical Solutions Group plc is an independent developer and manufacturer of tissue-healing technology, focused on quality outcomes for patients. Its surgical products, including tissue adhesives, suture, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, Peters Surgical, Ifabond, Vitalitec and Seal-G. It also supplies wound care dressings, such as silver alginates, alginates and foams through its ActivHeal brand, and under white label. Its Surgical Business Unit includes tissue adhesives, sutures, biosurgical devices and internal fixation devices. The Woundcare Business Unit comprises a multi-product portfolio of advanced woundcare dressings and a portfolio of specialist medical bulk materials and multi-layer woundcare and bio-diagnostics products. Its products are manufactured in the United Kingdom, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel.

Number of employees: 1,800

Sales by Activity: Advanced Medical Solutions Group plc

Fiscal Period: December 2021 (GBP) 2022 (GBP) 2023 (GBP) 2024 (GBP) 2025 (GBP)

Surgical

64.63M 74.86M 79.09M 136M 183M

Woundcare

43.97M 49.47M 47.12M 41.75M 45.48M

Geographical breakdown of sales: Advanced Medical Solutions Group plc

Fiscal Period: December 2021 (GBP) 2022 (GBP) 2023 (GBP) 2024 (GBP) 2025 (GBP)

Rest of Europe

18.75M 32.52M 38.93M 46.31M 62.47M

United States of America

36.71M 40.81M 31.88M 43.38M 53.89M

Rest of The World

9.66M 10.26M 11.65M 24.14M 36.85M

Germany

20.86M 20.78M 26.36M 32.29M 30.99M

France

4.16M - - 14.79M 25.06M

United Kingdom

18.45M 19.96M 17.38M 16.61M 19.68M

Executive Committee: Advanced Medical Solutions Group plc

Manager TitleAgeSince
Chief Executive Officer 60 31/12/2010
Director of Finance/CFO 54 31/12/2018
Chief Tech/Sci/R&D Officer - 30/06/2022
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 28/02/2026

Composition of the Board of Directors: Advanced Medical Solutions Group plc

Director TitleAgeSince
Director/Board Member 60 31/12/2010
Director/Board Member 54 31/12/2018
Chairman 68 30/03/2025
Director/Board Member 60 01/08/2021
Director/Board Member 63 30/03/2025
Director/Board Member 60 29/06/2025

Shareholders: Advanced Medical Solutions Group plc

NameStocks%Valuation
Investec Wealth & Investment Ltd.
5.937 %
13,036,909 5.937 % 48 M p
Rathbones Investment Management Ltd.
4.945 %
10,858,780 4.945 % 40 M p
Sand Grove Capital Management LLP
2.901 %
6,370,647 2.901 % 24 M p
Lombard Odier Asset Management (Europe) Ltd.
2.709 %
5,950,000 2.709 % 22 M p
Alpine Associates Management, Inc.
2.498 %
5,485,489 2.498 % 20 M p

Company details: Advanced Medical Solutions Group plc

Advanced Medical Solutions Group Plc

Winsford Industrial Estate

CW7 3RT, Winsford

+44 1606 863 500

http://admedsol.com
address Advanced Medical Solutions Group plc(AMS)

Medical Supplies

Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.18%+40.45%+22.86% 817M
+1.32%+3.37%-31.39%-47.96% 14.08B
-3.92%-0.80%+57.56%+106.57% 4.44B
-2.54%-7.95%+299.08%+189.70% 3.3B
+4.74%+8.90%-21.02%-27.13% 2.52B
+2.62%+6.97%-40.57%-66.44% 1.98B
+3.69%+8.59%-20.66%-19.55% 1.95B
+1.54%-0.75%-5.04%-23.70% 1.28B
+0.58%+5.49%+27.21%+35.16% 988M
+1.09%+8.18%-5.32%-10.10% 978M
Average +0.90%+3.07%+30.03%+15.94% 3.23B
Weighted average by Cap. +0.54%+2.32%+20.91%+6.18%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
2.795GBP
Average target price
2.900GBP
Spread / Average Target
+3.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMS Stock
  4. Company Advanced Medical Solutions Group plc